Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.

Bibliographic Details
Title: Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
Authors: Martín-Carbonero, L.1, Sánchez-Somolinos, M.1, García-Samaniego, J.2, Núñez, M. J.1, Valencia, M. E.1, González-Lahoz, J.1, Soriano, V.1 vsoriano@dragonet.es
Source: Journal of Viral Hepatitis. Dec2006, Vol. 13 Issue 12, p851-857. 7p. 2 Charts, 2 Graphs.
Subject Terms: *HIV, *HIGHLY active antiretroviral therapy, *HEPATITIS B virus, *HEPATITIS C virus, *LIVER diseases
Abstract: Since the advent of highly active antiretroviral therapy (HAART), complications of chronic liver disease (CLD) have emerged as one of the leading causes of hospital admission and death among HIV-infected patients with chronic hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections. The impact of CLD on hospital admissions and deaths in HIV-infected patients attended at one reference HIV hospital in Madrid during the last 9 years was analysed. All clinical charts from January 1996 to December 2004 were retrospectively examined. Demographics, discharge diagnosis, complications during inhospital stay and causes of death were recorded. A total of 2527 hospital admissions in 2008 distinct HIV-infected persons were recorded. Overall, 84% were iv drug users; mean age was 37 years and the mean CD4 count was 224 cells/ μL. Both mean age and CD4 count significantly increased during the study period ( P < 0.01). Overall, 42% of hospitalized patients were on antiretroviral therapy. Decompensated CLD was the cause of admission and/or developed during hospitalization in 345 patients (14%). Admissions caused by decompensated CLD increased significantly from 9.1% (30/329) in 1996 to 26% (78/294) in 2002. A significant steady decline occurred since then, being 11% (29/253) in the year 2004. Similarly, inhospital liver-related deaths were 9% (5/54) in 1996, peaked to 59% (10/17) in 2001 and declined to 20% (3/15) in the year 2004. Chronic hepatitis C was responsible for admissions and/or deaths in 73.5% of CLD cases. In conclusion, the rate of liver-related hospital admissions and deaths among HIV-infected patients peaked in the year 2002 and has steadily declined since then. A slower progression to liver cirrhosis in patients on HAART, avoidance of hepatotoxic antiretroviral drugs and more frequent use of anti-HCV therapy in HIV/HCV-coinfected patients could account for this benefit. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Viral Hepatitis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=13520504&ISBN=&volume=13&issue=12&date=20061201&spage=851&pages=851-857&title=Journal of Viral Hepatitis&atitle=Reduction%20in%20liver-related%20hospital%20admissions%20and%20deaths%20in%20HIV-infected%20patients%20since%20the%20year%202002.&aulast=Mart%C3%ADn-Carbonero%2C%20L.&id=DOI:10.1111/j.1365-2893.2006.00778.x
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: a9h
DbLabel: Academic Search Complete
An: 23071958
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mart&#237;n-Carbonero%2C+L%2E%22&quot;&gt;Mart&#237;n-Carbonero, L.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22S&#225;nchez-Somolinos%2C+M%2E%22&quot;&gt;S&#225;nchez-Somolinos, M.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Garc&#237;a-Samaniego%2C+J%2E%22&quot;&gt;Garc&#237;a-Samaniego, J.&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22N&#250;&#241;ez%2C+M%2E+J%2E%22&quot;&gt;N&#250;&#241;ez, M. J.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Valencia%2C+M%2E+E%2E%22&quot;&gt;Valencia, M. E.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Gonz&#225;lez-Lahoz%2C+J%2E%22&quot;&gt;Gonz&#225;lez-Lahoz, J.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Soriano%2C+V%2E%22&quot;&gt;Soriano, V.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; vsoriano@dragonet.es&lt;/i&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Journal+of+Viral+Hepatitis%22&quot;&gt;Journal of Viral Hepatitis&lt;/searchLink&gt;. Dec2006, Vol. 13 Issue 12, p851-857. 7p. 2 Charts, 2 Graphs.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: *&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22HIV%22&quot;&gt;HIV&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22HIGHLY+active+antiretroviral+therapy%22&quot;&gt;HIGHLY active antiretroviral therapy&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22HEPATITIS+B+virus%22&quot;&gt;HEPATITIS B virus&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22HEPATITIS+C+virus%22&quot;&gt;HEPATITIS C virus&lt;/searchLink&gt;&lt;br /&gt;*&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22LIVER+diseases%22&quot;&gt;LIVER diseases&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Since the advent of highly active antiretroviral therapy (HAART), complications of chronic liver disease (CLD) have emerged as one of the leading causes of hospital admission and death among HIV-infected patients with chronic hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infections. The impact of CLD on hospital admissions and deaths in HIV-infected patients attended at one reference HIV hospital in Madrid during the last 9 years was analysed. All clinical charts from January 1996 to December 2004 were retrospectively examined. Demographics, discharge diagnosis, complications during inhospital stay and causes of death were recorded. A total of 2527 hospital admissions in 2008 distinct HIV-infected persons were recorded. Overall, 84% were iv drug users; mean age was 37 years and the mean CD4 count was 224 cells/ μL. Both mean age and CD4 count significantly increased during the study period ( P &lt; 0.01). Overall, 42% of hospitalized patients were on antiretroviral therapy. Decompensated CLD was the cause of admission and/or developed during hospitalization in 345 patients (14%). Admissions caused by decompensated CLD increased significantly from 9.1% (30/329) in 1996 to 26% (78/294) in 2002. A significant steady decline occurred since then, being 11% (29/253) in the year 2004. Similarly, inhospital liver-related deaths were 9% (5/54) in 1996, peaked to 59% (10/17) in 2001 and declined to 20% (3/15) in the year 2004. Chronic hepatitis C was responsible for admissions and/or deaths in 73.5% of CLD cases. In conclusion, the rate of liver-related hospital admissions and deaths among HIV-infected patients peaked in the year 2002 and has steadily declined since then. A slower progression to liver cirrhosis in patients on HAART, avoidance of hepatotoxic antiretroviral drugs and more frequent use of anti-HCV therapy in HIV/HCV-coinfected patients could account for this benefit. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Journal of Viral Hepatitis is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder&#39;s express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=23071958
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/j.1365-2893.2006.00778.x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 851
    Subjects:
      – SubjectFull: HIV
        Type: general
      – SubjectFull: HIGHLY active antiretroviral therapy
        Type: general
      – SubjectFull: HEPATITIS B virus
        Type: general
      – SubjectFull: HEPATITIS C virus
        Type: general
      – SubjectFull: LIVER diseases
        Type: general
    Titles:
      – TitleFull: Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martín-Carbonero, L.
      – PersonEntity:
          Name:
            NameFull: Sánchez-Somolinos, M.
      – PersonEntity:
          Name:
            NameFull: García-Samaniego, J.
      – PersonEntity:
          Name:
            NameFull: Núñez, M. J.
      – PersonEntity:
          Name:
            NameFull: Valencia, M. E.
      – PersonEntity:
          Name:
            NameFull: González-Lahoz, J.
      – PersonEntity:
          Name:
            NameFull: Soriano, V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 13520504
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal of Viral Hepatitis
              Type: main
ResultId 1